img

Global Tardive Dyskinesia Treatment Medicine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Tardive Dyskinesia Treatment Medicine Market Insights, Forecast to 2034

Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary and repetitive movements, often affecting the face, tongue, lips, and other parts of the body. It is most commonly associated with the long-term use of certain medications, particularly antipsychotic medications used to treat conditions like schizophrenia and bipolar disorder. Tardive dyskinesia can be a challenging condition to manage, and treatment options aim to alleviate symptoms and improve the quality of life for affected individuals.
Market Analysis and InsightsGlobal Tardive Dyskinesia Treatment Medicine Market
Global Tardive Dyskinesia Treatment Medicine market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Tardive Dyskinesia Treatment Medicine industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Tardive Dyskinesia Treatment Medicine market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Tardive Dyskinesia Treatment Medicine market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Teva Pharmaceutical
Neurocrine Biosciences
Sun Pharmaceutical
SteriMax
Adamas Pharmaceuticals (Supernus)
AbbVie
Segment by Type
Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
Botulinum Toxin
Others

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Tardive Dyskinesia Treatment Medicine introduction, etc. Tardive Dyskinesia Treatment Medicine Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Tardive Dyskinesia Treatment Medicine
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
1.2.3 Botulinum Toxin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tardive Dyskinesia Treatment Medicine Market Perspective (2018-2033)
2.2 Global Tardive Dyskinesia Treatment Medicine Growth Trends by Region
2.2.1 Tardive Dyskinesia Treatment Medicine Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Tardive Dyskinesia Treatment Medicine Historic Market Size by Region (2018-2023)
2.2.3 Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Region (2024-2033)
2.3 Tardive Dyskinesia Treatment Medicine Market Dynamics
2.3.1 Tardive Dyskinesia Treatment Medicine Industry Trends
2.3.2 Tardive Dyskinesia Treatment Medicine Market Drivers
2.3.3 Tardive Dyskinesia Treatment Medicine Market Challenges
2.3.4 Tardive Dyskinesia Treatment Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Tardive Dyskinesia Treatment Medicine by Players
3.1.1 Global Tardive Dyskinesia Treatment Medicine Revenue by Players (2018-2023)
3.1.2 Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Tardive Dyskinesia Treatment Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Tardive Dyskinesia Treatment Medicine, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Tardive Dyskinesia Treatment Medicine Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia Treatment Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia Treatment Medicine Revenue in 2022
3.5 Global Key Players of Tardive Dyskinesia Treatment Medicine Head office and Area Served
3.6 Global Key Players of Tardive Dyskinesia Treatment Medicine, Product and Application
3.7 Global Key Players of Tardive Dyskinesia Treatment Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia Treatment Medicine Breakdown Data by Type
4.1 Global Tardive Dyskinesia Treatment Medicine Historic Market Size by Type (2018-2023)
4.2 Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Type (2024-2033)
5 Tardive Dyskinesia Treatment Medicine Breakdown Data by Application
5.1 Global Tardive Dyskinesia Treatment Medicine Historic Market Size by Application (2018-2023)
5.2 Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
6.2 North America Tardive Dyskinesia Treatment Medicine Market Size by Type
6.2.1 North America Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023)
6.2.2 North America Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033)
6.2.3 North America Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
6.3 North America Tardive Dyskinesia Treatment Medicine Market Size by Application
6.3.1 North America Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023)
6.3.2 North America Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033)
6.3.3 North America Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
6.4 North America Tardive Dyskinesia Treatment Medicine Market Size by Country
6.4.1 North America Tardive Dyskinesia Treatment Medicine Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023)
6.4.3 North America Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
7.2 Europe Tardive Dyskinesia Treatment Medicine Market Size by Type
7.2.1 Europe Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023)
7.2.2 Europe Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033)
7.2.3 Europe Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
7.3 Europe Tardive Dyskinesia Treatment Medicine Market Size by Application
7.3.1 Europe Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023)
7.3.2 Europe Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033)
7.3.3 Europe Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
7.4 Europe Tardive Dyskinesia Treatment Medicine Market Size by Country
7.4.1 Europe Tardive Dyskinesia Treatment Medicine Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023)
7.4.3 Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
8.2 China Tardive Dyskinesia Treatment Medicine Market Size by Type
8.2.1 China Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023)
8.2.2 China Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033)
8.2.3 China Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
8.3 China Tardive Dyskinesia Treatment Medicine Market Size by Application
8.3.1 China Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023)
8.3.2 China Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033)
8.3.3 China Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
9.2 Asia Tardive Dyskinesia Treatment Medicine Market Size by Type
9.2.1 Asia Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023)
9.2.2 Asia Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033)
9.2.3 Asia Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
9.3 Asia Tardive Dyskinesia Treatment Medicine Market Size by Application
9.3.1 Asia Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023)
9.3.2 Asia Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033)
9.3.3 Asia Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
9.4 Asia Tardive Dyskinesia Treatment Medicine Market Size by Region
9.4.1 Asia Tardive Dyskinesia Treatment Medicine Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Tardive Dyskinesia Treatment Medicine Market Size by Region (2018-2023)
9.4.3 Asia Tardive Dyskinesia Treatment Medicine Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Details
11.1.2 Teva Pharmaceutical Business Overview
11.1.3 Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Introduction
11.1.4 Teva Pharmaceutical Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.1.5 Teva Pharmaceutical Recent Developments
11.2 Neurocrine Biosciences
11.2.1 Neurocrine Biosciences Company Details
11.2.2 Neurocrine Biosciences Business Overview
11.2.3 Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Introduction
11.2.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.2.5 Neurocrine Biosciences Recent Developments
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Details
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Introduction
11.3.4 Sun Pharmaceutical Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.3.5 Sun Pharmaceutical Recent Developments
11.4 SteriMax
11.4.1 SteriMax Company Details
11.4.2 SteriMax Business Overview
11.4.3 SteriMax Tardive Dyskinesia Treatment Medicine Introduction
11.4.4 SteriMax Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.4.5 SteriMax Recent Developments
11.5 Adamas Pharmaceuticals (Supernus)
11.5.1 Adamas Pharmaceuticals (Supernus) Company Details
11.5.2 Adamas Pharmaceuticals (Supernus) Business Overview
11.5.3 Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Introduction
11.5.4 Adamas Pharmaceuticals (Supernus) Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.5.5 Adamas Pharmaceuticals (Supernus) Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Tardive Dyskinesia Treatment Medicine Introduction
11.6.4 AbbVie Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
11.6.5 AbbVie Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors
Table 3. Key Players of Botulinum Toxin
Table 4. Key Players of Others
Table 5. Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Tardive Dyskinesia Treatment Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Tardive Dyskinesia Treatment Medicine Market Share by Region (2018-2023)
Table 9. Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Tardive Dyskinesia Treatment Medicine Market Share by Region (2024-2033)
Table 11. Tardive Dyskinesia Treatment Medicine Market Trends
Table 12. Tardive Dyskinesia Treatment Medicine Market Drivers
Table 13. Tardive Dyskinesia Treatment Medicine Market Challenges
Table 14. Tardive Dyskinesia Treatment Medicine Market Restraints
Table 15. Global Tardive Dyskinesia Treatment Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Tardive Dyskinesia Treatment Medicine Revenue Share by Players (2018-2023)
Table 17. Global Top Tardive Dyskinesia Treatment Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia Treatment Medicine as of 2022)
Table 18. Global Tardive Dyskinesia Treatment Medicine Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Tardive Dyskinesia Treatment Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Tardive Dyskinesia Treatment Medicine, Headquarters and Area Served
Table 21. Global Key Players of Tardive Dyskinesia Treatment Medicine, Product and Application
Table 22. Global Key Players of Tardive Dyskinesia Treatment Medicine, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Type (2018-2023)
Table 26. Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Tardive Dyskinesia Treatment Medicine Revenue Market Share by Type (2024-2033)
Table 28. Global Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Tardive Dyskinesia Treatment Medicine Revenue Share by Application (2018-2023)
Table 30. Global Tardive Dyskinesia Treatment Medicine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Tardive Dyskinesia Treatment Medicine Revenue Share by Application (2024-2033)
Table 32. North America Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Tardive Dyskinesia Treatment Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Tardive Dyskinesia Treatment Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Tardive Dyskinesia Treatment Medicine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Tardive Dyskinesia Treatment Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Tardive Dyskinesia Treatment Medicine Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size by Country (2024-2033) & (US$ Million)
Table 64. Teva Pharmaceutical Company Details
Table 65. Teva Pharmaceutical Business Overview
Table 66. Teva Pharmaceutical Tardive Dyskinesia Treatment Medicine Product
Table 67. Teva Pharmaceutical Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 68. Teva Pharmaceutical Recent Developments
Table 69. Neurocrine Biosciences Company Details
Table 70. Neurocrine Biosciences Business Overview
Table 71. Neurocrine Biosciences Tardive Dyskinesia Treatment Medicine Product
Table 72. Neurocrine Biosciences Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 73. Neurocrine Biosciences Recent Developments
Table 74. Sun Pharmaceutical Company Details
Table 75. Sun Pharmaceutical Business Overview
Table 76. Sun Pharmaceutical Tardive Dyskinesia Treatment Medicine Product
Table 77. Sun Pharmaceutical Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 78. Sun Pharmaceutical Recent Developments
Table 79. SteriMax Company Details
Table 80. SteriMax Business Overview
Table 81. SteriMax Tardive Dyskinesia Treatment Medicine Product
Table 82. SteriMax Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 83. SteriMax Recent Developments
Table 84. Adamas Pharmaceuticals (Supernus) Company Details
Table 85. Adamas Pharmaceuticals (Supernus) Business Overview
Table 86. Adamas Pharmaceuticals (Supernus) Tardive Dyskinesia Treatment Medicine Product
Table 87. Adamas Pharmaceuticals (Supernus) Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 88. Adamas Pharmaceuticals (Supernus) Recent Developments
Table 89. AbbVie Company Details
Table 90. AbbVie Business Overview
Table 91. AbbVie Tardive Dyskinesia Treatment Medicine Product
Table 92. AbbVie Revenue in Tardive Dyskinesia Treatment Medicine Business (2018-2023) & (US$ Million)
Table 93. AbbVie Recent Developments
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Tardive Dyskinesia Treatment Medicine Market Share by Type: 2022 VS 2033
Figure 3. Vesicular Monoamine Transporter 2 (Vmat2) Inhibitors Features
Figure 4. Botulinum Toxin Features
Figure 5. Others Features
Figure 6. Global Tardive Dyskinesia Treatment Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Tardive Dyskinesia Treatment Medicine Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Tardive Dyskinesia Treatment Medicine Report Years Considered
Figure 12. Global Tardive Dyskinesia Treatment Medicine Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Tardive Dyskinesia Treatment Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Tardive Dyskinesia Treatment Medicine Market Share by Region: 2022 VS 2033
Figure 15. Global Tardive Dyskinesia Treatment Medicine Market Share by Players in 2022
Figure 16. Global Top Tardive Dyskinesia Treatment Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia Treatment Medicine as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Tardive Dyskinesia Treatment Medicine Revenue in 2022
Figure 18. North America Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
Figure 20. North America Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
Figure 21. North America Tardive Dyskinesia Treatment Medicine Market Share by Country (2018-2033)
Figure 22. United States Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Tardive Dyskinesia Treatment Medicine Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
Figure 26. Europe Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
Figure 27. Europe Tardive Dyskinesia Treatment Medicine Market Share by Country (2018-2033)
Figure 28. Germany Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Tardive Dyskinesia Treatment Medicine Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
Figure 36. China Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
Figure 37. Asia Tardive Dyskinesia Treatment Medicine Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
Figure 39. Asia Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
Figure 40. Asia Tardive Dyskinesia Treatment Medicine Market Share by Region (2018-2033)
Figure 41. Japan Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Tardive Dyskinesia Treatment Medicine Market Share by Country (2018-2033)
Figure 51. Brazil Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Tardive Dyskinesia Treatment Medicine Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 58. Neurocrine Biosciences Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 59. Sun Pharmaceutical Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 60. SteriMax Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 61. Adamas Pharmaceuticals (Supernus) Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 62. AbbVie Revenue Growth Rate in Tardive Dyskinesia Treatment Medicine Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed